Predicting decline of kidney function in lupus nephritis using urine biomarkers

Lupus

Volumn 25, Issue 9, 2016, Pages 1012-1018

  Abulaban, K M ^a,h   Song, H ^b   Zhang, X ^b   Kimmel, P L ^c   Kusek, J W ^c   Nelson, R G ^c   Feldman, H I ^d   Vasan, R S ^e   Ying, J ^f   Mauer, M ^g   Nelsestuen, G L ^g   Bennett, M ^a   Brunner, H I ^a   Rovin, B H ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

biomarker; kidney injury; lupus nephritis; renal function decline; SLE

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; FATTY ACID BINDING PROTEIN; HEPCIDIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TAMM HORSFALL GLYCOPROTEIN; TRANSFERRIN; CCL2 PROTEIN, HUMAN; UMOD PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER TYPE FATTY ACID BINDING PROTEIN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RENAL FUNCTION DECLINE; UNIVARIATE ANALYSIS; URINE LEVEL; ADOLESCENT; CHILD; KIDNEY FUNCTION TEST; LUPUS NEPHRITIS; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHEMOKINE CCL2; CHILD; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEPCIDINS; HUMANS; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSFERRIN; UROMODULIN; YOUNG ADULT;

EID: 84978200159     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316631629     Document Type: Article

References (19)

1. Costenbader KH, Desai A, Alarcon GS, et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 2011; 63: 1681-1688.
2. Hiraki LT, Lu B, Alexander SR, et al. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum 2011; 63: 1988-1997.
3. Suzuki M, Wiers K, Brooks EB, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009; 65: 530-536.
4. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN,. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 2005; 16: 467-473.
5. Siasos G, Tousoulis D, Michalea S, et al. Novel biomarkers assessing renal function in heart failure: relation to inflammatory status and cardiac remodelling. Curr Med Chem 2014; 21: 3976-3983.
6. Hammad A, Mosaad Y, Elhanbly S, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Lupus 2013; 22: 486-491.
7. Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009; 60: 2772-2781.
8. Brunner HI, Bennett MR, Mina R, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 2012; 64: 2687-2697.
9. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
10. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
11. Boss GR, Seegmiller JE,. Age-related physiological changes and their clinical significance. Western J Med 1981; 135: 434-440.
12. Schwartz G, Haycock G, Edelmann C, Spitzer A,. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
13. Ricci Z, Cruz DN, Ronco C,. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol 2011; 7: 201-208.
14. McGee S,. Simplifying likelihood ratios. J Gen Intern Med 2002; 17: 646-649.
15. Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN,. Arterial disease in chronic kidney disease. Heart 2013; 99: 365-372.
16. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
17. Mohammed MF, Belal D, Bakry S, et al. A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus. J Clin Lab Anal 2014; 28: 306-309.
18. Singh RG, Usha, Rathore SS, Behura SK, Singh NK,. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 2012; 21: 1214-1218.
19. Zhang X, Nagaraja HN, Nadasdy T, et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int 2012; 81: 401-406.